Drug Database
Back to search

Netherlands· NL-ab0bbeb174e8

Palsonify 20 mg filmomhulde tabletten

A paltusotine product containing paltusotinehydrochloride, registered in Netherlands by Crinetics Pharmaceuticals Europe GmbH. The same ATC class is registered in 9 of our 19 countries.

ATC H01CB06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPalsonify 20 mg filmomhulde tablettenATCH01CB06REGISTER NO.NL-ab0bbeb174e8PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about paltusotinehydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Paltusotine is registered in 9 of 19 countries.

Countries holding a registration under ATC H01CB06 (paltusotine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search paltusotine products by name

Paltusotine · ATC H01CB06

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PALTUSOTINEHYDROCHLORIDE
Manufacturer
Crinetics Pharmaceuticals Europe GmbH
Country
Netherlands (NL)
ATC code
H01CB06
ATC class
Paltusotine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/26/2021

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Paltusotine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paltusotine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Palsonify
  • Norway · Palsonify

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/430f7b7f-88de-43e4-8ac3-2f0e2bd7c7b7
GET /v1/drugs/430f7b7f-88de-43e4-8ac3-2f0e2bd7c7b7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/palsonify-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Paltusotine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134970",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOVIDON (E 1208)",
    "CROSPOVIDON (E 1202)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910, 50 mPa.s (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "PALTUSOTINEHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2026/04/23",
  "procedure_number": "EMEA/H/C/006636",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/26/2021",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about paltusotine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console